GSK923295
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK923295, covering 2018-07-12 to 2018-07-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer [Phase 1]